Sipa1l3 - signal-induced proliferation-associated 1 like 3 Gene
Species: Rattus norvegicus
Summary
Predicted to enable GTPase activator activity. Predicted to be involved in several processes, including activation of GTPase activity; epithelial cell morphogenesis; and establishment of epithelial cell polarity. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be located in several cellular components, including nucleoplasm; stress fiber; and tricellular tight junction. Predicted to be active in Golgi apparatus and plasma membrane. Human ortholog(s) of this gene implicated in cataract 45. Orthologous to human SIPA1L3 (signal induced proliferation associated 1 like 3). [provided by Alliance of Genome Resources, Apr 2022]
Sipa1l3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001371098.1 | NP_001358027.1 | signal-induced proliferation-associated 1-like protein 3 |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| is active in glutamatergic synapse |
IDA
IDA: Inferred from direct assay
|
26364583 | RGD |
| is active in glutamatergic synapse |
IMP
IMP: Inferred from mutant phenotype
|
26364583 | RGD |
| is active in postsynaptic specialization, intracellular component |
IDA
IDA: Inferred from direct assay
|
26364583 | RGD |
| is active in postsynaptic specialization, intracellular component |
IMP
IMP: Inferred from mutant phenotype
|
26364583 | RGD |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
signal-induced proliferation-associated 1-like protein 3 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS12931 | SIPA1L3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service